Author:
Jung Younghee,Lee Seung Soon,Song Wonkeun,Kim Han-Sung,Uh Young
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference29 articles.
1. Community-onset disease caused by Citrobacter freundii producing a novel CTX-M beta-lactamase, CTX-M-30, in Canada;Abdalhamid;Antimicrob Agents Chemother,2004
2. In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin);Bauernfeind;Infection,1991
3. Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use;Carmine;Drugs,1983
4. Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure;Chia;Microb Drug Resist,2010
5. Performance standards for antimicrobial susceptibility tesing;twenty-fifth informational supplement information supplement. Document M100-S25. Wayne, PA;Clinical and Laboratory Standards Institute (CLSI),2015